Concepts (181)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Patient Readmission | 7 | 2024 | 164 | 2.190 |
Why?
|
| Patient Discharge | 7 | 2022 | 153 | 2.110 |
Why?
|
| Retrospective Studies | 15 | 2023 | 2471 | 1.210 |
Why?
|
| Transitional Care | 2 | 2024 | 19 | 1.060 |
Why?
|
| Hospitals | 3 | 2022 | 76 | 0.890 |
Why?
|
| Delivery of Health Care, Integrated | 5 | 2022 | 531 | 0.870 |
Why?
|
| Practice Patterns, Physicians' | 4 | 2022 | 324 | 0.870 |
Why?
|
| Telemedicine | 2 | 2024 | 185 | 0.790 |
Why?
|
| Humans | 37 | 2025 | 17707 | 0.780 |
Why?
|
| Dexamethasone | 1 | 2022 | 12 | 0.780 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2022 | 26 | 0.770 |
Why?
|
| Papillomavirus Infections | 4 | 2025 | 139 | 0.760 |
Why?
|
| Medical Audit | 2 | 2020 | 35 | 0.700 |
Why?
|
| Emergency Service, Hospital | 8 | 2023 | 377 | 0.690 |
Why?
|
| Outpatients | 2 | 2020 | 107 | 0.690 |
Why?
|
| Medical Records | 2 | 2020 | 97 | 0.680 |
Why?
|
| Self Report | 2 | 2022 | 252 | 0.640 |
Why?
|
| Aged | 19 | 2024 | 6150 | 0.630 |
Why?
|
| Disease Progression | 1 | 2020 | 266 | 0.630 |
Why?
|
| Uterine Cervical Neoplasms | 3 | 2025 | 125 | 0.600 |
Why?
|
| Female | 28 | 2025 | 12729 | 0.590 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2020 | 196 | 0.590 |
Why?
|
| Male | 23 | 2023 | 10094 | 0.580 |
Why?
|
| Research Design | 1 | 2020 | 372 | 0.560 |
Why?
|
| Skilled Nursing Facilities | 1 | 2017 | 7 | 0.560 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2017 | 55 | 0.540 |
Why?
|
| Adult | 16 | 2025 | 7658 | 0.540 |
Why?
|
| Acute Coronary Syndrome | 3 | 2021 | 18 | 0.530 |
Why?
|
| Middle Aged | 20 | 2025 | 7976 | 0.520 |
Why?
|
| Patient Selection | 1 | 2017 | 190 | 0.520 |
Why?
|
| Aged, 80 and over | 9 | 2020 | 1927 | 0.520 |
Why?
|
| Mass Screening | 5 | 2025 | 667 | 0.510 |
Why?
|
| Anti-Bacterial Agents | 4 | 2020 | 137 | 0.510 |
Why?
|
| Medicare | 1 | 2017 | 199 | 0.490 |
Why?
|
| Myocardial Infarction | 3 | 2023 | 234 | 0.490 |
Why?
|
| Exercise | 1 | 2020 | 496 | 0.480 |
Why?
|
| Lung Neoplasms | 1 | 2017 | 260 | 0.440 |
Why?
|
| Electronic Health Records | 7 | 2020 | 694 | 0.420 |
Why?
|
| Early Detection of Cancer | 5 | 2025 | 513 | 0.410 |
Why?
|
| Sinusitis | 3 | 2017 | 14 | 0.410 |
Why?
|
| California | 12 | 2025 | 2327 | 0.400 |
Why?
|
| Pandemics | 3 | 2024 | 286 | 0.390 |
Why?
|
| Bariatric Surgery | 2 | 2023 | 128 | 0.350 |
Why?
|
| Risk Assessment | 5 | 2023 | 1106 | 0.330 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2017 | 211 | 0.310 |
Why?
|
| Guideline Adherence | 4 | 2017 | 155 | 0.290 |
Why?
|
| Follow-Up Studies | 3 | 2021 | 1218 | 0.280 |
Why?
|
| Craniocerebral Trauma | 2 | 2017 | 10 | 0.280 |
Why?
|
| Troponin | 2 | 2023 | 10 | 0.260 |
Why?
|
| Tissue Plasminogen Activator | 2 | 2016 | 23 | 0.260 |
Why?
|
| Breast Neoplasms | 3 | 2022 | 956 | 0.250 |
Why?
|
| Chest Pain | 2 | 2023 | 15 | 0.220 |
Why?
|
| Stroke | 2 | 2016 | 316 | 0.210 |
Why?
|
| Sampling Studies | 2 | 2020 | 48 | 0.200 |
Why?
|
| Aftercare | 1 | 2022 | 48 | 0.190 |
Why?
|
| Neoplasm Staging | 3 | 2017 | 331 | 0.190 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2024 | 381 | 0.190 |
Why?
|
| United States | 4 | 2017 | 3914 | 0.190 |
Why?
|
| Practice Guidelines as Topic | 4 | 2017 | 314 | 0.190 |
Why?
|
| Cohort Studies | 3 | 2023 | 2589 | 0.190 |
Why?
|
| Community Health Services | 1 | 2022 | 80 | 0.180 |
Why?
|
| Troponin I | 1 | 2021 | 8 | 0.180 |
Why?
|
| Papillomavirus Vaccines | 1 | 2022 | 113 | 0.180 |
Why?
|
| Critical Pathways | 1 | 2021 | 11 | 0.180 |
Why?
|
| Dementia | 1 | 2023 | 112 | 0.180 |
Why?
|
| Clinical Decision-Making | 1 | 2021 | 34 | 0.180 |
Why?
|
| Obesity, Morbid | 1 | 2022 | 120 | 0.180 |
Why?
|
| Patient Portals | 1 | 2021 | 24 | 0.170 |
Why?
|
| Telephone | 1 | 2021 | 161 | 0.170 |
Why?
|
| Referral and Consultation | 1 | 2022 | 165 | 0.170 |
Why?
|
| Heart Diseases | 1 | 2021 | 75 | 0.170 |
Why?
|
| Surveys and Questionnaires | 3 | 2024 | 1322 | 0.170 |
Why?
|
| Exercise Test | 1 | 2020 | 45 | 0.170 |
Why?
|
| Hospitals, Community | 2 | 2017 | 23 | 0.160 |
Why?
|
| House Calls | 1 | 2019 | 11 | 0.160 |
Why?
|
| Hospice and Palliative Care Nursing | 1 | 2019 | 7 | 0.160 |
Why?
|
| Regression Analysis | 1 | 2020 | 296 | 0.160 |
Why?
|
| Home Care Services | 1 | 2019 | 24 | 0.160 |
Why?
|
| Cost-Benefit Analysis | 1 | 2019 | 243 | 0.150 |
Why?
|
| Physician-Patient Relations | 1 | 2020 | 185 | 0.150 |
Why?
|
| Algorithms | 1 | 2020 | 237 | 0.150 |
Why?
|
| Registries | 2 | 2017 | 470 | 0.150 |
Why?
|
| Education, Continuing | 1 | 2017 | 3 | 0.140 |
Why?
|
| Antimicrobial Stewardship | 1 | 2017 | 6 | 0.140 |
Why?
|
| Heart Failure | 1 | 2023 | 398 | 0.140 |
Why?
|
| Delivery of Health Care | 2 | 2022 | 397 | 0.140 |
Why?
|
| Health Care Costs | 1 | 2019 | 222 | 0.140 |
Why?
|
| Income | 1 | 2017 | 88 | 0.140 |
Why?
|
| Depression | 1 | 2022 | 504 | 0.140 |
Why?
|
| Survival Analysis | 1 | 2017 | 216 | 0.140 |
Why?
|
| Patient Satisfaction | 1 | 2017 | 204 | 0.130 |
Why?
|
| Odds Ratio | 4 | 2021 | 670 | 0.130 |
Why?
|
| Prospective Studies | 4 | 2023 | 1287 | 0.130 |
Why?
|
| Fibrinolytic Agents | 1 | 2016 | 44 | 0.130 |
Why?
|
| Unnecessary Procedures | 1 | 2015 | 23 | 0.130 |
Why?
|
| Prognosis | 1 | 2017 | 613 | 0.120 |
Why?
|
| Comorbidity | 1 | 2017 | 590 | 0.120 |
Why?
|
| Critical Care | 1 | 2016 | 70 | 0.120 |
Why?
|
| Diagnostic Imaging | 1 | 2015 | 45 | 0.120 |
Why?
|
| Accelerometry | 1 | 2015 | 39 | 0.120 |
Why?
|
| Colorectal Neoplasms | 1 | 2021 | 616 | 0.120 |
Why?
|
| Biomarkers, Tumor | 1 | 2015 | 144 | 0.120 |
Why?
|
| Papillomaviridae | 2 | 2025 | 58 | 0.120 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2014 | 34 | 0.120 |
Why?
|
| Preventive Health Services | 1 | 2016 | 151 | 0.110 |
Why?
|
| Walking | 1 | 2015 | 86 | 0.110 |
Why?
|
| Air Pollutants | 1 | 2014 | 52 | 0.110 |
Why?
|
| Maternal Exposure | 1 | 2014 | 62 | 0.110 |
Why?
|
| Air Pollution | 1 | 2014 | 42 | 0.110 |
Why?
|
| Internet | 1 | 2016 | 229 | 0.110 |
Why?
|
| Population Surveillance | 1 | 2015 | 265 | 0.110 |
Why?
|
| Ambulatory Care | 1 | 2015 | 241 | 0.110 |
Why?
|
| Health Maintenance Organizations | 1 | 2015 | 414 | 0.100 |
Why?
|
| Primary Health Care | 2 | 2017 | 756 | 0.100 |
Why?
|
| Chronic Disease | 1 | 2016 | 416 | 0.100 |
Why?
|
| Longitudinal Studies | 3 | 2023 | 717 | 0.100 |
Why?
|
| Logistic Models | 3 | 2020 | 918 | 0.090 |
Why?
|
| Weight Loss | 2 | 2023 | 305 | 0.080 |
Why?
|
| Body Mass Index | 1 | 2014 | 970 | 0.080 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2024 | 387 | 0.080 |
Why?
|
| Decision Support Systems, Clinical | 2 | 2017 | 54 | 0.070 |
Why?
|
| Canada | 2 | 2017 | 66 | 0.070 |
Why?
|
| Acute Disease | 2 | 2017 | 141 | 0.060 |
Why?
|
| Positron-Emission Tomography | 2 | 2015 | 30 | 0.060 |
Why?
|
| Papanicolaou Test | 1 | 2024 | 37 | 0.060 |
Why?
|
| Vaginal Smears | 1 | 2024 | 48 | 0.060 |
Why?
|
| Perception | 1 | 2024 | 57 | 0.060 |
Why?
|
| Mammography | 2 | 2015 | 168 | 0.060 |
Why?
|
| Child | 2 | 2022 | 2481 | 0.050 |
Why?
|
| Sleep | 1 | 2022 | 58 | 0.050 |
Why?
|
| Pragmatic Clinical Trials as Topic | 1 | 2022 | 61 | 0.050 |
Why?
|
| Social Class | 1 | 2022 | 121 | 0.050 |
Why?
|
| Medical Oncology | 1 | 2022 | 32 | 0.050 |
Why?
|
| Angina, Unstable | 1 | 2021 | 7 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2022 | 327 | 0.050 |
Why?
|
| Coronary Angiography | 1 | 2021 | 19 | 0.050 |
Why?
|
| Percutaneous Coronary Intervention | 1 | 2021 | 22 | 0.040 |
Why?
|
| Coronary Artery Bypass | 1 | 2021 | 25 | 0.040 |
Why?
|
| Socioeconomic Factors | 1 | 2023 | 626 | 0.040 |
Why?
|
| Residence Characteristics | 1 | 2023 | 248 | 0.040 |
Why?
|
| Government Programs | 1 | 2020 | 11 | 0.040 |
Why?
|
| Health Priorities | 1 | 2020 | 24 | 0.040 |
Why?
|
| Patient Education as Topic | 1 | 2022 | 212 | 0.040 |
Why?
|
| Research Personnel | 1 | 2020 | 28 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2020 | 60 | 0.040 |
Why?
|
| Occult Blood | 1 | 2021 | 154 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2020 | 304 | 0.040 |
Why?
|
| Natural Language Processing | 1 | 2020 | 58 | 0.040 |
Why?
|
| Oregon | 1 | 2019 | 187 | 0.040 |
Why?
|
| Infant | 1 | 2023 | 1199 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2022 | 1254 | 0.040 |
Why?
|
| Biomarkers | 1 | 2020 | 312 | 0.040 |
Why?
|
| Sex Factors | 1 | 2021 | 639 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2023 | 1417 | 0.040 |
Why?
|
| Washington | 1 | 2019 | 382 | 0.040 |
Why?
|
| Young Adult | 2 | 2015 | 2450 | 0.040 |
Why?
|
| Vaccination | 1 | 2022 | 656 | 0.040 |
Why?
|
| Professional-Patient Relations | 1 | 2017 | 46 | 0.040 |
Why?
|
| Hospitalization | 1 | 2023 | 805 | 0.040 |
Why?
|
| Interrupted Time Series Analysis | 1 | 2017 | 25 | 0.040 |
Why?
|
| Adolescent | 2 | 2015 | 3671 | 0.030 |
Why?
|
| Hemorrhage | 1 | 2016 | 62 | 0.030 |
Why?
|
| Bone Neoplasms | 1 | 2015 | 10 | 0.030 |
Why?
|
| Mid-Atlantic Region | 1 | 2015 | 9 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2017 | 371 | 0.030 |
Why?
|
| Northwestern United States | 1 | 2015 | 53 | 0.030 |
Why?
|
| Neoplasm Grading | 1 | 2015 | 49 | 0.030 |
Why?
|
| Risk Factors | 1 | 2023 | 3367 | 0.030 |
Why?
|
| Monitoring, Physiologic | 1 | 2015 | 40 | 0.030 |
Why?
|
| Insurance Coverage | 1 | 2016 | 105 | 0.030 |
Why?
|
| Vehicle Emissions | 1 | 2014 | 23 | 0.030 |
Why?
|
| Outcome Assessment (Health Care) | 1 | 2016 | 227 | 0.030 |
Why?
|
| Age Distribution | 1 | 2015 | 246 | 0.030 |
Why?
|
| Survivors | 1 | 2015 | 158 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 355 | 0.030 |
Why?
|
| Environmental Exposure | 1 | 2014 | 117 | 0.030 |
Why?
|
| Health Promotion | 1 | 2016 | 280 | 0.030 |
Why?
|
| Healthcare Disparities | 1 | 2015 | 203 | 0.030 |
Why?
|
| Time Factors | 1 | 2015 | 1095 | 0.020 |
Why?
|
| Smoking | 1 | 2014 | 483 | 0.020 |
Why?
|
| Pregnancy | 1 | 2014 | 1535 | 0.020 |
Why?
|
Concepts
(181)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(20)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_
-->